You have failed to present any information to suggest there is any red flag. I have to ask a second time, would you not PR a planned meeting with the FDA to discuss the PE data? Would you not have a meeting at all to discuss PE data? It would be insane to do that, to simply ignore the FDA in a p3 trial?
News 
Market Data 
Discover 
